arrow
F

Francesca Farina

IRCCS San Raffaele Scientific Institute
H指数:32
被引数:3,802

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Empirical Therapy in High-Risk Hematological Patients with Carbapenem-Resistant Enterobacterales Colonization: Real-World Treatment Decisions and Antimicrobial Stewardship Implications

在高风险血液病患者中,对碳青霉烯耐药肠杆菌科细菌定植的的经验性治疗:真实世界治疗决策和抗菌药物合理使用的影响

2026-10-080
OA
Association between baseline circulating FGF21 levels and depressive symptoms at follow up in older adults: evidence from the FRASNET cohort

基线循环FGF21水平与老年人群随访期间抑郁症状之间的关联:FRASNET队列研究证据

2026-04-100
OAAI
Circulating Mitokines GDF-15 and FGF21 are associated with Frailty, Sarcopenia, and Malnutrition in Older Adults: Evidence from the FRASNET Study

循环线粒体因子GDF-15和FGF21与老年人群的虚弱、肌肉减少症和营养不良相关:FRASNET研究证据

2025-11-110
PRE
Validation of Manhattan risk to predict aGvHD severity in Rapamycin and PTCy-based prophylaxis: a study on 459 consecutive HCT patients

验证Manhattan风险评分在Rapamycin和PTCy为基础的预防方案中预测aGvHD严重程度的价值:一项针对459例连续HCT患者的研究

2025-07-210
PRE
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study

I型戈谢病在冒烟型或多发性骨髓瘤患者中的患病率:来自前瞻性、观察性CHAGAL研究的结果

2025-01-220
OAAI
Frailty index, frailty phenotype and 6-year mortality trends in the FRASNET cohort

FRASNET队列的虚弱指数,虚弱表型和6年死亡率趋势

2025-01-080
OAAI
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report
2024-12-230
OAAI
Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group
2024-10-280
PRE
Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients
2024-09-201
OAAI
Macrophage derived immunotherapy in glioblastoma: Phase I TEM-GBM-001 results

巨噬细胞来源的免疫疗法在胶质母细胞瘤中的应用:TEM-GBM-001 Ⅰ期研究结果

2024-09-010
PRE
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey (vol 52, pg 1125, 2024)

重症新型冠状病毒肺炎和血液系统恶性肿瘤患者的ICU需求和结局: EPICOVIDEHA调查结果 (第52卷,1125页,2024页)

2024-05-210
OAAI
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022
2024-05-015
OAAI
A macrophages-based immunotherapy of solid tumors microenvironment: Preliminary results of the TEM-GBM_01 study
2024-04-050
PRE
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry

地塞米松治疗新型冠状病毒肺炎与血液系统恶性肿瘤患者的死亡率增加有关: EPICOVIDEHA注册表的结果

2024-04-042
OAAI
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

重症新型冠状病毒肺炎和血液系统恶性肿瘤患者的ICU需求和结局: EPICOVIDEHA调查的结果

2024-02-224
OAAI
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies
2024-01-061
OAAI